Abstract
Purpose
The quest of specialized oncology services represents an inelastic need for cancer patients that often leads to traveling in order to receive adequate care. The present survey assesses patient geographic mobility to access services for the prevention and treatment of neoplasmatic diseases in Greece, a country where the National Health System is characterized by severe misdistribution of oncology-specific resources.
Methods
Based on data from the National Statistical Service for 1999–2005 (last available), we estimated geographic mobility as the difference between oncology patients residing in a specific region and those receiving care in National Health System (NHS) facilities located in the region, for the ten administrative districts of Greece. Especially for Attica, we performed a sub-analysis according to cancer diagnosis.
Results
The most significant mobility is towards Attica, where patients receiving care within the region outnumber the patients actually residing by 48.9% annually, on average. Positive flows are also observed towards Macedonia (8.4%) and Epirus (7.8%). Negative flows are recorded in all remaining regions, the highest noticed in Sterea (−76.2%), Ionian Islands (−63.3%), Aegean Islands (−45.2%), and Thessaly (−37.3%). The largest flow towards Attica is for cases of malignant neoplasms of the skin, uterus, male genital organs, and for Hodgkin’s lymphomas.
Conclusions
Misallocation of oncology-specific resources creates “two-tier” cancer patients based on ability to pay for traveling/accommodation. The severity and the consequences of the disease necessitate a bold approach to resource allocation and the establishment of integrated patient support networks that ensure all cancer patients are offered equal opportunities to effective treatment.
Similar content being viewed by others
References
World Health Organization (2001) The World Health Report 2001. WHO, Geneva
Ries LAG, Cl K, Hankey BF et al (1999) SEER cancer statistics review, 1973–1996. National Cancer Institute, Bethesda
World Health Organization (2004): Global Burden of Disease Estimates. Death and DALY estimates for 2002 by WHO member state. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates_2000_2002/en/index.html. Accessed on: 26 Feb 2010
Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML (2008) Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 100:888–897
Jordan H, Roderick P, Martin D, Barnett S (2004) Distance, rurality and the need for care: access to health services in South West England. Int J Health Geogr. doi:10.1186/1476-072X-3-21
Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL (2007) Patient time costs associated with cancer care. J Natl Cancer Inst 99:14–23
Yabroff KR, Warren JL, Knopf K, Davis WW, Brown ML (2005) Estimating patient time costs associated with colorectal cancer care. Med Care 43:640–648
Kessler LG, Ramsey SD (2007) The forest and the trees: the human costs of cancer. J Natl Cancer Inst 99:2–3
Lysdahl KB, Borretzen L (2007) Geographical variation in radiological services: a nationwide survey. BMC Health Serv Res 7:21
Schweikhart SB, Smithdaniels VL (1993) Location and service mix decisions for a managed health-care network. Socio Econ Plann Sci 27:289–302
Jayaraman V, Srivastava R (1995) A service logistics model for simultaneous siting of facilities and multiple levels of equipment. Comput Oper Res 22:191–204
Chiu LF (2003). Inequalities of access to cancer screening: a literature review. Cancer Screening Series No. 1, December. NHS Cancer Screening Programmes, Sheffield, UK
Souliotis K, Athanasakis K, Golna C, Papadopoulou C, Kyriopoulos J (2009) Availability and spatial contribution of oncology specific resources in Greece. Doc Greek Med 26:808–817
Souliotis K (2007) Economic inequalities and health policy. Papazisis Publishers, Athens
Guidry JJ, Aday LA, Zhang D, Winn RJ (1997) Transportation as a barrier to cancer treatment. Cancer Pract 5:361–366
Giokas D (2001) Greek Hospitals: how well their resources are used. Omega 29:73–83
Efstathiou N, Ameen J, Coll AM (2007) Healthcare providers’ priorities for cancer care: a Delphi study in Greece. Eur J Oncol Nurs 11:141–151
Organization for Economic Co-operation and Development (OECD)—Working Party on Social Policy, Human Resources for Health Care Systems (2002) Geographical imbalances of HRHC: size, determinants and policy responses. OECD, Paris
Dussault G, Francescini MC (2006) Not enough there, too many here: understanding geographical imbalances in the distribution of the health workforce. Hum Resour Health 4:12
Souliotis K (2001) Approach of the social and regional inequalities in health in Greece. Topos 17:49–74
Tountas Y, Karnaki P, Pavi E, Souliotis K (2005) The “unexpected” growth of the private health sector in Greece. Health Policy 74(2):167–180
Payne SN, Jarrett N, Jeffs D (2000) The impact of travel on cancer patients’ experience of treatment: a literature review. Eur J Cancer Care 9:197–203
Fitch MI, Gray RE, Mcgowan T, Brunskill I, Steggles S, Sellick S, Bezjak A, McLeese D (2005) Τravelling for radiation cancer treatment: patient satisfaction. Can Oncol Nurs J 15:107–119
Martin-McDonald K, Rogers-Clark C, Hegney D, McCarthy A, Pearce S (2003) Experiences of regional and rural people with cancer being treated with radiotherapy in a metropolitan centre. Int J Nurs Pract 9:176–182
Hegney D, Pearce S, Rogers-Clark C, Martin-McDonald K, Buikstra E (2005) Close, but still too far. The experience of Australian people with cancer commuting from a regional to a capital city for radiotherapy treatment. Eur J Cancer Care Engl 14:75–82
Davis C, Girgis A, Williams P, Beeney L (1998) Needs assessment of rural and remote women travelling to the city for breast cancer treatment. Aust N Z J Public Health 22:525–527
Rosato R, Sacerdote C, Pagano E, Di Cuonzo D, Baldi I, Bordon R, Ponti A, Bertetto O, Segnan N, Merletti F, Vineis P, Ciccone G (2009) Appropriateness of early breast cancer management in relation to patient and hospital characteristics: a population-based study in Northern Italy. Breast Cancer Res Treat 117:349–356
Dejardin O, Remontet L, Bouvier AM, Danzon A, Trétarre B, Delafosse P, Molinié F, Maarouf N, Velten M, Sauleau EA, Bourdon-Raverdy N, Grosclaude P, Boutreux S, De Pouvourville G, Launoy G (2006) Socioeconomic and geographic determinants of survival of patients with digestive cancer in France. Br J Cancer 95:944–949
Jack RH, Gulliford MC, Ferguson J, Møller H (2003) Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? Br J Cancer 88:1025–1031
Sariego J (2009) Patterns of breast cancer presentation in the United States: does geography matter? Am Surg 75:545–549
Sariego J (2008) Regional variation in breast cancer treatment throughout the United States. Am J Surg 196:572–574
Sowden A, Aletras V, Place M, Rice N, Eastwood A, Grilli R, Ferguson B, Posnett J, Sheldon T (1997) Volume of clinical activity in hospitals and healthcare outcomes, costs, and patient access. Qual Health Care 6:109–114
Bain NSC, Campbell NC, Ritchie LD, Cassidy J (2002) Striking the right balance in colorectal cancer care—a qualitative study of rural and urban patients. Farm Pract 19:369–374
Mandelblatt JS, Yabroff R, Kerner JF (1999) Equitable access to cancer services: a review to barriers to quality care. Cancer 86:2378–2390
Blumenthal S (2002) The effects of socioeconomic status on health in rural and urban America. JAMA 287:109
Acknowledgments
The present study was financially supported by Roche (Hellas) S.A.
Conflict of interest
The authors declare no conflicts of interest.
We also declare that we have full control of all primary data and agree to allow the journal to review the data, if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Athanasakis, K., Souliotis, K., Kyriopoulos, EJ. et al. Inequalities in access to cancer treatment: an analysis of cross-regional patient mobility in Greece. Support Care Cancer 20, 455–460 (2012). https://doi.org/10.1007/s00520-011-1093-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1093-0